Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | PHGDH | O43175 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.41 |
| ▸ | POLB | P06746 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 4/20 | 0.40 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.40 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8977229 | 1.00 | FAAH (0.48) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL7105501 | 0.98 | FAAH (0.47) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL8054344 | 0.98 | FAAH (0.45) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL9957386 | 0.95 | — | — | |
| SCHEMBL8053344 | 0.87 | — | — | |
| SCHEMBL27862797 | 0.82 | FAAH (0.45) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL8977352 | 0.80 | ALDH1A1 (0.35) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL17704770 | 0.80 | FAAH (0.52) | FAAHPHGDHMGLLTSHRHPGD | |
| SCHEMBL7994505 | 0.79 | TSHR (0.38) | TSHRHPGDALDH1A1 | |
| SCHEMBL16424652 | 0.79 | EPHX1 (0.41) | TSHRALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747247-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2026-05-27 | — | — | EP | disclosed |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-09-09 | — | — | US | disclosed |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-04-24 | — | — | US | disclosed |
| WO-2025015420-A1 | NOVEL FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-01-23 | — | — | WO | disclosed |
| US-11078163-B2 | Processes for the synthesis of substituted urea compounds | Bial-Portela & Cª, S.A. (PT) | 2021-08-03 | — | — | US | disclosed |
| CN-105934431-B | Process for preparing substituted urea compounds | 比亚尔-珀特拉和CA股份公司 | 2020-11-17 | — | — | CN | disclosed |
| US-20200140391-A1 | Processes for the Synthesis of Substituted Urea Compounds | BIAL-PORTELA & CA, S.A. (PT) | 2020-05-07 | — | — | US | disclosed |
| US-10583140-B2 | Ingenol analogs, pharmaceutical compositions and methods of use thereof | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2020-03-10 | — | — | US | disclosed |
| EP-3097082-B1 | PROCESSES FOR THE SYNTHESIS OF SUBSTITUTED UREA COMPOUNDS | BIAL PORTELA & CA SA (PT) | 2019-10-02 | — | — | EP | disclosed |
| US-20190030029-A1 | INGENOL ANALOGS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-01-31 | — | — | US | disclosed |
| US-5403816-A | Picolinic acid derivative and herbicidal composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-04-04 | — | — | US | disclosed |
| EP-0567133-A1 | Picolinic acid derivative and herbicidal composition | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1993-10-27 | — | — | EP | disclosed |
| US-4973588-A | IMPROVED BRAIN FUNCTION AT REDUCED OXYGEN LEVELS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1990-11-27 | — | — | US | disclosed |
| US-4067726-A | 3-Ureido phenylacetamide herbicides | BAYER AKTIENGESELLSCHAFT (DT) | 1978-01-10 | — | — | US | disclosed |
| US-4053298-A | HERBICIDAL COMPOSITIONS CONTAINING 1-THIADIAZOLYL-6-CARBAMOYLOXYTETRAHYDROPYRIMIDINONES AND METHODS THEREFOR | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-11 | — | — | US | disclosed |
| US-4023957-A | Herbicidal 1-thiadiazolyl-5-carbamoyloxyimidazolidinones | VELSICOL CHEMICAL CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-3989710-A | POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3978107-A | NOVEL CYCLOHEXYL CARBAMATES AND HERBICIDAL AND ACARICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-31 | — | — | US | disclosed |
| US-3951976-A | 1-Thiadiazoly-6-carbamoyloxytetrahydropyrimidinones | VELSICOL CHEMICAL CORPORATION (US) | 1976-04-20 | — | — | US | disclosed |
| US-3937824-A | COMPOSITIONS AND METHODS OF KILLING INSECTS AND ACARIDS USING ALKOXYIMINO CARBAMOYLOXY PHOSPHORUS COMPOUNDS | VELSICOL CHEMICAL CORPORATION (US) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200140391-A1 | Processes for the Synthesis of Substituted Urea Compounds | GRHPR, REN, ODC1 | FAAH 3163/4885PHGDH 1126/4885MGLL 3511/4885 |
| US-20250129027-A1 | FATTY ACID AMIDE HYDROLASE MODULATORS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF | FAAH, FAAH2, MGLL | FAAH 1/4885PHGDH 181/4885MGLL 3/4885 |
| US-12410137-B2 | Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof | FAAH, FAAH2, MGLL | FAAH 1/4885PHGDH 181/4885MGLL 3/4885 |
| US-20190030029-A1 | INGENOL ANALOGS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF | ERG28, PTH1R, CCR5 | FAAH 3126/4885PHGDH 2157/4885MGLL 309/4885 |
| US-10583140-B2 | Ingenol analogs, pharmaceutical compositions and methods of use thereof | ERG28, PTH1R, CCR5 | FAAH 3126/4885PHGDH 2157/4885MGLL 309/4885 |
| US-11078163-B2 | Processes for the synthesis of substituted urea compounds | GRHPR, REN, ODC1 | FAAH 3163/4885PHGDH 1126/4885MGLL 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.